These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16299335

  • 1. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
    Page KR, Jedlicka AE, Fakheri B, Noland GS, Kesavan AK, Scott AL, Kumar N, Manabe YC.
    Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
    [Abstract] [Full Text] [Related]

  • 2. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T, Shen J, Chou B, Duan X, Tu L, Tetsutani K, Moriya C, Ishida H, Hamano S, Shimokawa C, Hisaeda H, Himeno K.
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [Abstract] [Full Text] [Related]

  • 3. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC, Wassom DL.
    J Immunol; 1988 Jul 01; 141(1):241-8. PubMed ID: 3379305
    [Abstract] [Full Text] [Related]

  • 4. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
    Kobayashi F, Ishida H, Matsui T, Tsuji M.
    J Vet Med Sci; 2000 Jun 01; 62(6):583-7. PubMed ID: 10907683
    [Abstract] [Full Text] [Related]

  • 5. Co-infection: the outcome of Plasmodium infection differs according to the time of pre-existing helminth infection.
    Salazar-Castañón VH, Juárez-Avelar I, Legorreta-Herrera M, Govezensky T, Rodriguez-Sosa M.
    Parasitol Res; 2018 Sep 01; 117(9):2767-2784. PubMed ID: 29938323
    [Abstract] [Full Text] [Related]

  • 6. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
    Ishih A, Kawakami C, Todoroki A, Hirai H, Ohori K, Kobayashi F.
    Parasitol Res; 2013 Feb 01; 112(2):773-80. PubMed ID: 23180129
    [Abstract] [Full Text] [Related]

  • 7. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
    Singh RP, Kashiwamura S, Rao P, Okamura H, Mukherjee A, Chauhan VS.
    J Immunol; 2002 May 01; 168(9):4674-81. PubMed ID: 11971017
    [Abstract] [Full Text] [Related]

  • 8. Expression of non-TLR pattern recognition receptors in the spleen of BALB/c mice infected with Plasmodium yoelii and Plasmodium chabaudi chabaudi AS.
    Rosanas-Urgell A, Martin-Jaular L, Ricarte-Filho J, Ferrer M, Kalko S, Kimura E, Del Portillo HA.
    Mem Inst Oswaldo Cruz; 2012 May 01; 107(3):410-5. PubMed ID: 22510838
    [Abstract] [Full Text] [Related]

  • 9. Plasmodium yoelii: assessment of production and role of nitric oxide during the early stages of infection in susceptible and resistant mice.
    Wang QH, Liu YJ, Liu J, Chen G, Zheng W, Wang JC, Cao YM.
    Exp Parasitol; 2009 Mar 01; 121(3):268-73. PubMed ID: 19109953
    [Abstract] [Full Text] [Related]

  • 10. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
    Qi Z, Han X, Zhang Y, Wang J, Cao YM.
    Tohoku J Exp Med; 2013 Feb 01; 229(2):87-96. PubMed ID: 23303295
    [Abstract] [Full Text] [Related]

  • 11. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
    Blank J, Behrends J, Jacobs T, Schneider BE.
    Infect Immun; 2016 Feb 01; 84(2):502-10. PubMed ID: 26644378
    [Abstract] [Full Text] [Related]

  • 12. MAPK phosphotase 5 deficiency contributes to protection against blood-stage Plasmodium yoelii 17XL infection in mice.
    Cheng Q, Zhang Q, Xu X, Yin L, Sun L, Lin X, Dong C, Pan W.
    J Immunol; 2014 Apr 15; 192(8):3686-96. PubMed ID: 24634491
    [Abstract] [Full Text] [Related]

  • 13. Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia.
    Couper KN, Blount DG, Hafalla JC, van Rooijen N, de Souza JB, Riley EM.
    Infect Immun; 2007 Dec 15; 75(12):5806-18. PubMed ID: 17923512
    [Abstract] [Full Text] [Related]

  • 14. Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria.
    Shear HL, Marino MW, Wanidworanun C, Berman JW, Nagel RL.
    Am J Trop Med Hyg; 1998 Dec 15; 59(6):852-8. PubMed ID: 9886187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T, Bhattacharyya A.
    Exp Parasitol; 2014 Jun 15; 141():82-92. PubMed ID: 24675415
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
    Kobayashi F, Morii T, Matsui T, Fujino T, Watanabe Y, Weidanz WP, Tsuji M.
    Parasitol Res; 1996 Jun 15; 82(5):385-91. PubMed ID: 8738275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.